Announcements Trials
Browse Landscape

Phase

Phase 2 81Phase 3 30Phase 1 29Phase 1/2 20Phase NA 5Phase 2/3 3Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 7NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pirtobrutinib 1ibritumomab tiuxetan 1epacadostat 1entinostat 1corticorelin ovine 1amatuximab 1Tetrahydrouridine 1Technetium Tc 99m Medronate 1Stem Cell Transplantation 1Specimen Handling 1Sodium Chloride 1Sodium 1Salpingo-oophorectomy 1Rituximab 1Radiation 1QL1206 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Peripheral Blood Stem Cell Transplantation 1N-(N-((S)-1,3-Dicarboxypropyl)carbamoyl)-4-(18F)fluorobenzyl-L-cysteine 1Midazolam 1Microscopy, Electron 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Ketamine 1Imiquimod 1Hysterectomy 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × NIH × Filgrastim × Clear all
NCT00017381 2013-01-09

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡